EcoDrugPlus

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSDLEG00000006950
Gene Symbol: FGFR1
3 Cross references
293 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSDLEG00000008001
Gene Symbol: FGFR2
3 Cross references
218 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSDLEG00000016588
Gene Symbol: FGFR3
3 Cross references
196 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSDLEG00000011349
Gene Symbol: FGFR4
3 Cross references
122 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSDLEG00000015551
Gene Symbol: FLT1
3 Cross references
199 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSDLEG00000014957
Gene Symbol: FLT3
3 Cross references
134 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSDLEG00000017328
Gene Symbol: FLT4
3 Cross references
198 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSDLEG00000003393
Gene Symbol: FOLH1
3 Cross references
211 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSDLEG00000000312
Gene Symbol: FOLR1
3 Cross references
203 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSDLEG00000000519
Gene Symbol: FSHR
3 Cross references
200 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSDLEG00000002995
Gene Symbol: FFAR1
3 Cross references
76 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSDLEG00000002986
Gene Symbol: FFAR2
3 Cross references
339 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).